David Young Chung, M.D.,Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cortical Spreading Depression | 20 | 2023 | 288 | 4.430 |
Why?
|
| Subarachnoid Hemorrhage | 15 | 2023 | 1032 | 3.870 |
Why?
|
| Hydrocephalus | 4 | 2021 | 763 | 1.320 |
Why?
|
| Head Injuries, Closed | 2 | 2022 | 133 | 0.920 |
Why?
|
| Brain Ischemia | 8 | 2024 | 3127 | 0.850 |
Why?
|
| Vasospasm, Intracranial | 3 | 2021 | 215 | 0.740 |
Why?
|
| Ventriculostomy | 2 | 2018 | 131 | 0.680 |
Why?
|
| Cerebrospinal Fluid Shunts | 2 | 2019 | 195 | 0.680 |
Why?
|
| Posterior Leukoencephalopathy Syndrome | 2 | 2020 | 50 | 0.670 |
Why?
|
| Cerebrovascular Circulation | 7 | 2024 | 2733 | 0.630 |
Why?
|
| Brain Stem Hemorrhage, Traumatic | 1 | 2017 | 13 | 0.580 |
Why?
|
| Drainage | 2 | 2021 | 1161 | 0.580 |
Why?
|
| Pupil Disorders | 1 | 2017 | 32 | 0.570 |
Why?
|
| Cerebral Cortex | 5 | 2022 | 5761 | 0.550 |
Why?
|
| Intracranial Hypertension | 1 | 2018 | 193 | 0.510 |
Why?
|
| Intracranial Aneurysm | 5 | 2021 | 1276 | 0.440 |
Why?
|
| Brain Concussion | 2 | 2022 | 1394 | 0.430 |
Why?
|
| Visual Cortex | 1 | 2020 | 1089 | 0.420 |
Why?
|
| Oximetry | 1 | 2016 | 461 | 0.410 |
Why?
|
| Cerebral Angiography | 2 | 2021 | 1274 | 0.380 |
Why?
|
| Disease Models, Animal | 13 | 2024 | 18137 | 0.380 |
Why?
|
| Migraine with Aura | 3 | 2020 | 203 | 0.330 |
Why?
|
| Disease Management | 1 | 2019 | 2514 | 0.320 |
Why?
|
| KCNQ1 Potassium Channel | 1 | 2009 | 103 | 0.320 |
Why?
|
| Infarction, Middle Cerebral Artery | 4 | 2024 | 485 | 0.310 |
Why?
|
| Mice, Inbred C57BL | 12 | 2024 | 22020 | 0.310 |
Why?
|
| Potassium Channels, Voltage-Gated | 1 | 2009 | 141 | 0.300 |
Why?
|
| Brain Injuries | 1 | 2019 | 2044 | 0.300 |
Why?
|
| Evidence-Based Medicine | 1 | 2019 | 3696 | 0.290 |
Why?
|
| Seizures | 4 | 2024 | 2917 | 0.290 |
Why?
|
| Mice, Transgenic | 8 | 2024 | 9530 | 0.280 |
Why?
|
| Disulfides | 1 | 2009 | 466 | 0.270 |
Why?
|
| Animals | 31 | 2024 | 167960 | 0.240 |
Why?
|
| Intensive Care Units | 2 | 2020 | 3736 | 0.240 |
Why?
|
| Hypoventilation | 1 | 2024 | 44 | 0.230 |
Why?
|
| Cysteine | 1 | 2009 | 895 | 0.230 |
Why?
|
| Mice | 21 | 2024 | 81209 | 0.220 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2021 | 36286 | 0.210 |
Why?
|
| Endovascular Procedures | 4 | 2024 | 2134 | 0.210 |
Why?
|
| Apnea | 1 | 2024 | 195 | 0.210 |
Why?
|
| Behavior, Animal | 2 | 2020 | 1866 | 0.210 |
Why?
|
| Neurons | 3 | 2024 | 9424 | 0.190 |
Why?
|
| Weaning | 1 | 2021 | 103 | 0.190 |
Why?
|
| CADASIL | 1 | 2022 | 88 | 0.190 |
Why?
|
| Embolization, Therapeutic | 2 | 2021 | 1412 | 0.190 |
Why?
|
| Head Injuries, Penetrating | 1 | 2021 | 28 | 0.190 |
Why?
|
| Leukoaraiosis | 1 | 2022 | 116 | 0.190 |
Why?
|
| Rotarod Performance Test | 1 | 2020 | 63 | 0.180 |
Why?
|
| Ventriculoperitoneal Shunt | 1 | 2021 | 186 | 0.180 |
Why?
|
| Phenytoin | 1 | 2020 | 188 | 0.170 |
Why?
|
| Cerebral Infarction | 2 | 2022 | 982 | 0.160 |
Why?
|
| Maze Learning | 1 | 2020 | 477 | 0.160 |
Why?
|
| Migraine Disorders | 3 | 2020 | 1693 | 0.160 |
Why?
|
| Transcytosis | 1 | 2018 | 45 | 0.160 |
Why?
|
| Anticonvulsants | 2 | 2020 | 1879 | 0.150 |
Why?
|
| Laser-Doppler Flowmetry | 1 | 2018 | 239 | 0.150 |
Why?
|
| Vagus Nerve Stimulation | 1 | 2020 | 224 | 0.140 |
Why?
|
| Caveolin 1 | 1 | 2018 | 257 | 0.140 |
Why?
|
| Brain | 4 | 2022 | 26951 | 0.140 |
Why?
|
| Pupil | 1 | 2017 | 141 | 0.130 |
Why?
|
| Hyperalgesia | 1 | 2020 | 530 | 0.130 |
Why?
|
| Endothelium | 1 | 2018 | 764 | 0.130 |
Why?
|
| Pericytes | 1 | 2018 | 293 | 0.130 |
Why?
|
| Length of Stay | 2 | 2021 | 6476 | 0.130 |
Why?
|
| Piracetam | 1 | 2016 | 88 | 0.130 |
Why?
|
| Aneurysm, Ruptured | 1 | 2020 | 460 | 0.120 |
Why?
|
| Somatosensory Cortex | 1 | 2019 | 511 | 0.120 |
Why?
|
| Intracranial Thrombosis | 1 | 2015 | 109 | 0.120 |
Why?
|
| Male | 24 | 2024 | 359718 | 0.120 |
Why?
|
| Anesthetics | 1 | 2019 | 522 | 0.110 |
Why?
|
| Cerebral Hemorrhage | 2 | 2023 | 2660 | 0.110 |
Why?
|
| Kainic Acid | 2 | 2024 | 199 | 0.100 |
Why?
|
| Humans | 24 | 2022 | 760613 | 0.100 |
Why?
|
| Light | 1 | 2018 | 1344 | 0.100 |
Why?
|
| Wakefulness | 1 | 2019 | 1255 | 0.100 |
Why?
|
| Hippocampus | 1 | 2024 | 3738 | 0.100 |
Why?
|
| Motor Cortex | 1 | 2019 | 995 | 0.100 |
Why?
|
| Depression | 2 | 2021 | 8045 | 0.090 |
Why?
|
| Cerebral Arteries | 1 | 2012 | 493 | 0.090 |
Why?
|
| Treatment Outcome | 5 | 2021 | 64981 | 0.080 |
Why?
|
| Dithiothreitol | 1 | 2009 | 95 | 0.080 |
Why?
|
| Blood Transfusion | 1 | 2016 | 1328 | 0.080 |
Why?
|
| Gene Knock-In Techniques | 2 | 2021 | 419 | 0.080 |
Why?
|
| Endothelium, Vascular | 1 | 2020 | 4434 | 0.080 |
Why?
|
| Prospective Studies | 3 | 2021 | 54306 | 0.070 |
Why?
|
| Oxygen | 1 | 2019 | 4193 | 0.070 |
Why?
|
| Blood Pressure | 3 | 2020 | 8525 | 0.070 |
Why?
|
| Corpus Callosum | 2 | 2022 | 749 | 0.070 |
Why?
|
| Cricetulus | 1 | 2009 | 815 | 0.070 |
Why?
|
| Retrospective Studies | 5 | 2021 | 80345 | 0.070 |
Why?
|
| CHO Cells | 1 | 2009 | 1389 | 0.070 |
Why?
|
| Protein Structure, Secondary | 1 | 2009 | 1229 | 0.060 |
Why?
|
| Anxiety | 1 | 2020 | 4538 | 0.060 |
Why?
|
| Cricetinae | 1 | 2009 | 2427 | 0.060 |
Why?
|
| Cognition | 1 | 2022 | 6964 | 0.060 |
Why?
|
| Stress, Psychological | 1 | 2019 | 4446 | 0.060 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2020 | 8158 | 0.060 |
Why?
|
| Female | 11 | 2021 | 391246 | 0.050 |
Why?
|
| Case-Control Studies | 1 | 2020 | 22052 | 0.050 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3085 | 0.050 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3205 | 0.050 |
Why?
|
| Brain Infarction | 1 | 2024 | 292 | 0.050 |
Why?
|
| Bicuculline | 1 | 2021 | 96 | 0.050 |
Why?
|
| Milrinone | 1 | 2021 | 86 | 0.050 |
Why?
|
| Desoxycorticosterone | 1 | 2020 | 46 | 0.050 |
Why?
|
| 4-Aminopyridine | 1 | 2021 | 80 | 0.050 |
Why?
|
| Potassium Channel Blockers | 1 | 2021 | 161 | 0.050 |
Why?
|
| rho-Associated Kinases | 1 | 2022 | 281 | 0.040 |
Why?
|
| Stroke | 1 | 2023 | 9952 | 0.040 |
Why?
|
| Pancreatic Elastase | 1 | 2020 | 128 | 0.040 |
Why?
|
| Tetrodotoxin | 1 | 2021 | 246 | 0.040 |
Why?
|
| Mice, Inbred ICR | 1 | 2020 | 364 | 0.040 |
Why?
|
| Rats | 3 | 2020 | 23709 | 0.040 |
Why?
|
| Hypoalbuminemia | 1 | 2020 | 87 | 0.040 |
Why?
|
| Inflammation | 1 | 2019 | 10755 | 0.040 |
Why?
|
| Endothelin-1 | 1 | 2020 | 302 | 0.040 |
Why?
|
| Scalp | 1 | 2022 | 389 | 0.040 |
Why?
|
| Vibrissae | 1 | 2019 | 116 | 0.040 |
Why?
|
| Hematoma | 1 | 2023 | 769 | 0.040 |
Why?
|
| Hyperemia | 1 | 2019 | 221 | 0.040 |
Why?
|
| Penicillins | 1 | 2021 | 407 | 0.040 |
Why?
|
| Potassium | 1 | 2022 | 1313 | 0.040 |
Why?
|
| Nervous System | 1 | 2021 | 543 | 0.040 |
Why?
|
| Valproic Acid | 1 | 2020 | 441 | 0.040 |
Why?
|
| Physical Stimulation | 1 | 2019 | 518 | 0.040 |
Why?
|
| Vagus Nerve | 1 | 2020 | 457 | 0.040 |
Why?
|
| Electroencephalography | 2 | 2024 | 6189 | 0.040 |
Why?
|
| Receptors, Notch | 1 | 2022 | 742 | 0.040 |
Why?
|
| Amino Acid Sequence | 1 | 2009 | 13451 | 0.040 |
Why?
|
| Injections | 1 | 2020 | 830 | 0.030 |
Why?
|
| Adult | 3 | 2021 | 220007 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2017 | 20509 | 0.030 |
Why?
|
| Multicenter Studies as Topic | 1 | 2021 | 1722 | 0.030 |
Why?
|
| Molecular Sequence Data | 1 | 2009 | 17624 | 0.030 |
Why?
|
| Tight Junctions | 1 | 2018 | 315 | 0.030 |
Why?
|
| Brain Stem | 1 | 2021 | 857 | 0.030 |
Why?
|
| Dogs | 1 | 2020 | 3841 | 0.030 |
Why?
|
| Drug Monitoring | 1 | 2020 | 965 | 0.030 |
Why?
|
| Swine | 1 | 2024 | 5899 | 0.030 |
Why?
|
| Electric Stimulation | 1 | 2019 | 1735 | 0.030 |
Why?
|
| Polymers | 1 | 2021 | 1621 | 0.030 |
Why?
|
| Rabbits | 1 | 2020 | 4773 | 0.030 |
Why?
|
| Monitoring, Physiologic | 1 | 2021 | 1784 | 0.030 |
Why?
|
| Evoked Potentials | 1 | 2019 | 1036 | 0.030 |
Why?
|
| Blood-Brain Barrier | 1 | 2018 | 1019 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2022 | 2985 | 0.020 |
Why?
|
| Host-Pathogen Interactions | 1 | 2020 | 1447 | 0.020 |
Why?
|
| Paraffin Embedding | 1 | 2012 | 302 | 0.020 |
Why?
|
| HIV Infections | 2 | 2020 | 17165 | 0.020 |
Why?
|
| Homeostasis | 1 | 2022 | 3306 | 0.020 |
Why?
|
| Pandemics | 2 | 2021 | 8623 | 0.020 |
Why?
|
| Middle Aged | 4 | 2020 | 220359 | 0.020 |
Why?
|
| Vasodilation | 1 | 2012 | 962 | 0.020 |
Why?
|
| Action Potentials | 1 | 2016 | 1816 | 0.020 |
Why?
|
| Critical Care | 1 | 2020 | 2699 | 0.020 |
Why?
|
| Critical Illness | 1 | 2020 | 2709 | 0.020 |
Why?
|
| Immunosuppressive Agents | 1 | 2020 | 4167 | 0.020 |
Why?
|
| Thrombolytic Therapy | 1 | 2015 | 2108 | 0.020 |
Why?
|
| Sex Factors | 1 | 2020 | 10546 | 0.020 |
Why?
|
| Survival Rate | 1 | 2020 | 12810 | 0.020 |
Why?
|
| Fibrinolytic Agents | 1 | 2015 | 2167 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2021 | 10343 | 0.010 |
Why?
|
| Brain Mapping | 1 | 2019 | 6569 | 0.010 |
Why?
|
| Aged, 80 and over | 2 | 2020 | 58980 | 0.010 |
Why?
|
| Time Factors | 1 | 2024 | 40139 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2021 | 25941 | 0.010 |
Why?
|
| Prognosis | 1 | 2020 | 29661 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2012 | 8556 | 0.010 |
Why?
|
| Mutation | 1 | 2022 | 29957 | 0.010 |
Why?
|
| Young Adult | 1 | 2020 | 58748 | 0.010 |
Why?
|
| Risk Factors | 1 | 2020 | 74333 | 0.010 |
Why?
|
| Aged | 1 | 2020 | 169143 | 0.000 |
Why?
|